PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-93.01%
Both yoy net incomes decline, with CRK at -2962.06%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-5.25%
Negative yoy D&A while CRK is 118.99%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-73.27%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-522.22%
Negative yoy SBC while CRK is 0.35%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-190.97%
Both reduce yoy usage, with CRK at -159.26%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-190.97%
Both reduce yoy usage, with CRK at -346.05%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-72.92%
Both negative yoy, with CRK at -105.49%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-62.50%
Both yoy CFO lines are negative, with CRK at -41.79%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-43.31%
Negative yoy CapEx while CRK is 5.42%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-243.86%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
43.31%
Purchases growth of 43.31% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
105.31%
Liquidation growth of 105.31% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-68.17%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-273.43%
We reduce yoy invests while CRK stands at 5.42%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-8211.11%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.